E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 

Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each.


Click on the deal summary to see the full details.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc. Greater of 12.25% and 12.25% plus the amount by which the Prime rate exceeds 3.25% due 42 months

Cell Therapeutics Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc. 10.000%

Cell Therapeutics, Inc. 10.000%

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics, Inc. 10.000% due 12/5/2011

Cell Therapeutics, Inc. 10.000% due 2012

Cell Therapeutics, Inc. 9.660% due 10/22/2008

Cell Therapeutics, Inc. 15.500% due 9/29/2012

Cell Therapeutics, Inc.

Cell Therapeutics, Inc. 18.330% due 7/24/2011

Cell Therapeutics, Inc. 18.330% due 7/24/2011

Cell Therapeutics, Inc. 15.000% due 3

Cell Therapeutics, Inc. 13.500%

Cell Therapeutics, Inc. 13.500% due 4/30/2014

Cell Therapeutics, Inc. 9.000% due 3/4/2012

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Cell Therapeutics Inc. 3.000%

Cell Therapeutics Inc. 3.000%

Cell Therapeutics Inc. 3.000%

Cell Therapeutics Inc. 3.000%

Cell Therapeutics Inc.

Cell Therapeutics Inc.

Cell Therapeutics Inc. 7.500% due 4/30/2011

Cell Therapeutics Inc. 7.500% due 4/30/2011

Cell Therapeutics Inc. 6.750% due 10/31/2010

Cell Therapeutics Inc. 4.000% due 6/15/2010



© 2012 Prospect News.
All content in this database is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.